1Eenshaw CM. Alterations inblood pressure//Copstead LC, Banask JL. Pathophysiology: Biological and behavioural perspective [ M ]. 2 nd. Philadelphia: WB Saundersco,2004:374 - 392.
2Williams B, Poulter NR, Brown M J, et al. Guidlines for management of hypertension:report of the fourth working party of the British Hypertension Society,2004 - BHS Ⅳ [ J ]. J Hum Hyperteus, 2004,18 ( 3 ) : 139 - 185.
3Di Bona GF. Sympathetic nervous system and the kidney in hypertension[ J]. Curt Opin Nephrol Hypertens,2002,11 ( 2 ) : 197 - 200.
4Chobanian AV, Barkris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressccre [ J ]. Hypertension, 2003,42 ( 7 ) : 1206 - 1252.
5Streeten DHP. Anderson GH. Seceendary hypertension : an overview of its cause and management[J]. Drugs,1992,43(9) :805 -819.
6Weinkerger MH. Systemic hypertension//Humes HD. Kelley's text book of internal medicine [ M ]. Philadelphia: Lippincott Williams and wilkins: lkins ,2000 : 191 - 201.
7Rossouw JE, Anderson GL, Rrentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:pricipal resuits from the women's hesoth intiateve randomized controlled trial[J]. JAMA,2002,288 (4) :321 -333.
8Geleijne JM, KoK FJ, Grobbee RE. Blood pressure to changesin sodium and potassium intake: a metaregresion analysis of randomized trials [ J ]. J Hum Hypertens,2003,17 ( 5 ) :471 - 480.
9Brody MJ,Barron KW,Bercek KH,et al. Neurogenic mechanism of experimental hypertension//Genest JK,Hamet P,Cantin M. Hypertension[ M ]. 2nd. New York:MC Grow Hill Book Co,1998:117-139.
10Hemmelgarn BR,Zarnke KB, Campkell NBC, et al. The 2004 Comadian Hypertension Progran recommendations for the managemeut of hypertension:part Ⅰ blood pressure measurement, diagnosis and assessment of risk[J]. Can J Cardiol,2004,20( 1 ) :31 -34.
